Results 241 to 250 of about 969,825 (379)

The complexity of dementia development and its comorbidities: The collaborative cross‐mouse population for multivarious tasks approach

Animal Models and Experimental Medicine, EarlyView.
The increasing prevalence of dementia and related neurodegenerative diseases—including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and amyotrophic lateral sclerosis—poses a growing public health challenge. These conditions have traditionally been studied as isolated central nervous system disorders, but emerging evidence points to ...
Osayd Zohud, Iqbal M. Lone, Kareem Midlej, Fuad A. Iraqi   +3 more
wiley   +1 more source

GutMicrobiotAware: an international exploratory survey on awareness and understanding of the gut microbiota. [PDF]

Front Microbiol
Garcia-Gutierrez E, Arbulu S, Oliver C, Kumar S, Dam SA, Jakobi B, Pennone V, Sarda FAH, Mukherjee A, Cotter PD.   +9 more
europepmc   +1 more source

Clinical Treatment and Clinical Application Research Progress of Psoriasis and Intestinal Microbiota Dysbiosis

Nana Zhao, Kejia Wang, Yang Jiang, Rongzhong Huang   +3 more
openalex   +2 more sources

Adherence to the Mediterranean and Mediterranean‐Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) Diets and Parkinson's Disease Incidence in Women: Results from the Prospective E3N Cohort

Annals of Neurology, EarlyView.
Objective The evidence regarding adherence to dietary patterns and Parkinson's disease (PD) risk is inconsistent. Because of the long prodromal PD phase, reverse causation represents a major threat to investigations of diet in relation to PD. We examined whether adherence to the Mediterranean (MED) and Mediterranean‐Dietary Approaches to Stop ...
Mariem Hajji‐Louati, Emmanuelle Correia, Pei‐Chen Lee, Fanny Artaud, Emmanuel Roze, Francesca Romana Mancini, Alexis Elbaz   +6 more
wiley   +1 more source

The gut microbiota influences neurodegenerative diseases through the gut-brain axis: molecular mechanisms and effects on immune function. [PDF]

Front Immunol
Yang J, Song X, Yan S, Li Q, Yang W.
europepmc   +1 more source

Advancements in enhancing resistant starch type 3 (RS3) content in starchy food and its impact on gut microbiota: A review [PDF]

Hongyan Feng, Bo Cheng, Jongbin Lim, Baoguo Li, Cheng Li, Xiaowei Zhang   +5 more
openalex   +1 more source

Advances and Challenges in Micro/Nanocarrier‐Based Dermal Drug Delivery Systems for Acne Treatment

Advanced NanoBiomed Research, EarlyView.
Topical acne treatment faces challenges from skin barriers and complex causes. Micro/nanocarriers improve drug delivery by enhancing bioavailability, targeting, and duration. Combining carriers creates synergistic effects for systematic intervention.
Jintao Yang, Jie Chen, Yunmiao Ma, Qingwei Zhou, Yu Kong, Yingxiang Chen, Junjie Chi, Haihua Hu   +7 more
wiley   +1 more source

Diet, Physical Exercise, and Gut Microbiota Modulation in Metabolic Syndrome: A Narrative Review. [PDF]

Life (Basel)
Onu A, Tutu A, Trofin DM, Onu I, Galaction AI, Onita CA, Iordan DA, Matei DV.   +7 more
europepmc   +1 more source

Data Sheet 1_Bank1 deficiency reshapes the gut microbiota of lupus mice towards an anti-inflammatory composition.pdf

Georgina Galicia (405104), María Botía-Sánchez (11323062), Daniel Toro-Dominguez (4689844), Ana López García (21752012), Juan Rafael Valera (21752015), Gonzalo Gómez Hernández (21752018), Raquel Marcos Fernandez (21752021), Noelia Carmona (21752024), Gracia Luque (21752027), María Morell (8993504), Nieves Varela (21752030), Francisco Pérez-Cozar (21752033), Abelardo Margolles (133949), Margarita Aguilera (345570), Marta E. Alarcón-Riquelme (7146965)   +14 more
openalex   +1 more source

Decoding the Pathophysiology of Autoimmune Diseases—Mechanism, Triggers, and Nanotherapeutics: A Review

Advanced NanoBiomed Research, EarlyView.
This review highlights how autoimmune diseases arise from intertwined immunological, genetic, and environmental factors, emphasizing gut microbiota dysbiosis as a pivotal driver. It outlines emerging nanotechnology‐based strategies—such as liposomes, hydrogels, and polymeric nanoparticles—that enhance targeted drug delivery, minimize systemic toxicity,
Md. Meraj Ansari, Yunhui Min, Eun‐Ju Ko, Doyoung Kwon, Rehan Khan, Young‐Ok Son   +5 more
wiley   +1 more source